GI & Endoscopy

Gastroenterology has been ripe with M&A activity in 2019. Whether through private equity, strategic acquisition or new partnership, 2019 is turning into a banner year for the specialty.

Here are four updates from gastroenterology companies from the past week:

Assembly Biosciences named former Gilead Sciences Chief Scientific Officer John McHutchison, MD, its new president and CEO, succeeding company co-founder Derek Small.

Vanessa M. Shami, MD, is the director of endoscopic ultrasound in the division of gastroenterology and hepatology at Charlottesville-based University of Virginia Medical Center.

Adam J. Goodman, MD, is section chief of gastroenterology at NYU Langone Hospital-Brooklyn in New York City.

The American College of Gastroenterology, American Gastroenterological Association and American Society for Gastrointestinal Endoscopy outlined how the proposed changes to the 2020 Physician Fee Schedule and Outpatient Prospective Payment System will affect gastroenterologists.

Here are five of the most read gastroenterology articles on Becker's ASC Review this week:

CRH Medical continues to bring in the revenue in 2019, posting $30.5 million in second quarter revenues, up from $27.3 million in the same period last year.

Bausch Health subsidiary Salix Pharmaceuticals settled an intellectual property case against Teva Pharmaceuticals over Salix's ulcerative colitis drug Apriso.

Physicians Endoscopy and Capital Digestive Care entered into a strategic partnership Aug. 1, which saw the two companies form a management platform.